GLP1R and heart failure: A meta-analysis concluded that GLP-1 RA, regardless of structural homology, reduced the risk of individual major adverse cardiovascular event components, all-cause mortality, hospital admission for heart failure, and worsening kidney function in patients with type 2 diabetes [36].